Redox ratio in the left ventricle of the growth restricted fetus is positively correlated with cardiac output.
Catherine G DimasiJoanna LazniewskaSally E PlushBrahmdeep S SainiStacey L HolmanSteven K S ChoMichael D WieseAlexandra SorvinaChristopher K MacgowanMichael SeedDoug A BrooksJanna L MorrisonJack R T DarbyPublished in: Journal of biophotonics (2021)
Intrauterine growth restriction (IUGR) is a result of limited substrate supply to the developing fetus in utero, and can be caused by either placental, genetic or environmental factors. Babies born IUGR can have poor long-term health outcomes, including being at higher risk of developing cardiovascular disease. Limited substrate supply in the IUGR fetus not only changes the structure of the heart but may also affect metabolism and function of the developing heart. We have utilised two imaging modalities, two-photon microscopy and phase-contrast MRI (PC-MRI), to assess alterations in cardiac metabolism and function using a sheep model of IUGR. Two-photon imaging revealed that the left ventricle of IUGR fetuses (at 140-141 d GA) had a reduced optical redox ratio, suggesting a reliance on glycolysis for ATP production. Concurrently, the use of PC-MRI to measure foetal left ventricular cardiac output (LVCO) revealed a positive correlation between LVCO and redox ratio in IUGR, but not control fetuses. These data suggest that altered heart metabolism in IUGR fetuses is indicative of reduced cardiac output, which may contribute to poor cardiac outcomes in adulthood.
Keyphrases
- left ventricular
- gestational age
- high resolution
- heart failure
- contrast enhanced
- cardiovascular disease
- magnetic resonance imaging
- mitral valve
- pulmonary hypertension
- type diabetes
- magnetic resonance
- depressive symptoms
- hypertrophic cardiomyopathy
- computed tomography
- acute myocardial infarction
- diffusion weighted imaging
- pulmonary artery
- single cell
- coronary artery disease
- metabolic syndrome
- machine learning
- coronary artery
- optical coherence tomography
- transcatheter aortic valve replacement
- congenital heart disease
- single molecule
- living cells
- data analysis
- cardiovascular events